Neptune Wellness Solutions - NEPT Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" NEPT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEPT, but not buy additional shares or sell existing shares.
View NEPT analyst ratings or view top-rated stocks.

Neptune Wellness Solutions' stock was trading at $0.3151 at the beginning of the year. Since then, NEPT stock has increased by 217.4% and is now trading at $1.00.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our NEPT earnings forecast.

Neptune Wellness Solutions Inc (NASDAQ:NEPT) released its quarterly earnings results on Friday, December, 16th. The biotechnology company reported ($0.79) EPS for the quarter. The biotechnology company earned $11.99 million during the quarter. Neptune Wellness Solutions had a negative trailing twelve-month return on equity of 75.30% and a negative net margin of 149.78%.

Neptune Wellness Solutions's stock reverse split on the morning of Monday, June 13th 2022. The 1-35 reverse split was announced on Monday, June 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Neptune Wellness Solutions issued an update on its second quarter 2023 earnings guidance on Friday, December, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $11.50 million-$12.50 million, compared to the consensus revenue estimate of $10.49 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Cara Therapeutics (CARA), Innovative Industrial Properties (IIPR), Zynerba Pharmaceuticals (ZYNE), Amarin (AMRN) and NewAge (NBEV).

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Neptune Wellness Solutions' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).

Shares of NEPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NEPT stock can currently be purchased for approximately $1.00.

Neptune Wellness Solutions (NASDAQ:NEPT) has a market capitalization of $11.85 million and generates $48.80 million in revenue each year. The biotechnology company earns $-74,970,000.00 in net income (profit) each year or ($14.1169) on an earnings per share basis.

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The official website for the company is www.neptunecorp.com. The biotechnology company can be reached via phone at 45-0687-2262, via email at m.paradis@neptunecorp.com, or via fax at 45-0687-2272.